Aşılamanın Dünü, Bugünü, Yarını

Yıl 2003, Cilt: 1 Sayı: 1, 5 - 9, 01.09.2003

İbrahim Ildırım

Öz

İnsanlar eski çağlarda da hastalıklardan korunmaya çalışmışlardır. Aşıların keşfinden önce insanlar doğal yolla hastalıklardan korunmak istemişler, bu nedenle bazı aileler suçiçeği veya kızamık hastalığı geçiren çocuklarının yanına, diğer kardeşlerini de yatırarak, onların da küçük yaşta bu hastalığı geçirmelerini, bir defada bu hastalıkları atlatmalarını düşünmüşlerdir. Buna hastalığı geçirerek kazanılmış bağışıklık diyoruz

Anahtar Kelimeler

Aşılamanın, Dünü, Bugünü

Kaynakça

• 1. Abbas AK,. Lichtman AH, Prober JS. Cellular and Molecular Immunology. WB Saunders Co: Phidelphia, 2000.
• 2. DeBary WT (ed). The Budhist Tradition in India. New York,Vintage Boks, 1972.
• 3. Huard PA.Wong K. Chinese , New York, McGrow-Hill, 1968.
• 4. Jenner E.Variolate Vaccinae. London, Low, 1798.
• 5. American Academy of Pediatrics. Poliovirus Infections. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Disease. 26th ed. Elk Grove Vilage, IL: American Academy of Pediatrics; 2003: 505-9.
• 6. Cherry JD. Historical review of pertusis and classical vaccine. Pediatr Infect Dis J 1997; 16: 90-96.
• 7. Stanley A Plotkin, Cadoz M. The acelluler pertusis vaccine trials: an interpretation. Pediatr Infect Dis J 1997; 16: 508-517.
• 8. American Academy of Pediatrics. Hepatitis B. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Disease. 26th ed. Elk Grove Vilage, IL: American Academy of Pediatrics; 2003: 318-336.
• 9. Levine OS, Schwartz B, Pierce N, Kane M. Development evaluation and implementation of Haemophilus Influenzae type b vaccine for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998; 17: 95-113.
• 10. Decker MD, Edwards KM. Haemophilus Influenzae type b vaccines: history, coice and comparisons. Pediatr Inf Dis J 1994; 17: 403-18.
• 11. Johnson CE, Stancin T, Fattler D, et al. A long-term prospective study of varicella in healty children. Pediatrics 1997; 100: 761-766.
• 12. CDC. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45.
• 13. Gruber WC. The role of live influenza vaccines in children. Vaccine 2002; 15 (20): 66-73.
• 14. Lee HJ, Kang JH, Henrichsen J, et al. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection, Vaccine 1995; 13:1533.
• 15. Anderson EL, Kennedy DJ, Geldmacher KM, et al: Immunogenicity of heptavalent pneumonococcal conjugate vaccine in infants, J Pediatr 1996; 128:649.
• 16. Lepow ML. Meningoccoccal vaccines. In: Plotkin SA, Mortimer EA (eds). Vaccines (2 nd ed.) Philadelphia: WB Saunders Company,994; 503-15.
• 17. Recommendations of the Advisory Committee on Immunization Practice (ACIP). Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. MMWR 1999; 48: 1-20.
• 18. Lutwick LI, Abramson JM. Pediatric immunization for the future. Pediatric Clinics of North America, Philadelphia: WB Saunders Company, 2000 ; 47(2):465-79.